Kuros Biosciences Ltd header image

Kuros Biosciences Ltd

KURN

Equity

ISIN CH0325814116 / Valor 32581411

SIX Swiss Exchange (2026-03-25)
CHF 22.62-6.14%

Kuros Biosciences Ltd
UMushroom community rating:

star star star star star
4.00 1 votes No rating yet
NegativeNeutralPositive

About company

Kuros Biosciences Ltd is a biotechnology company based in Switzerland, publicly traded on the SIX Swiss Stock Exchange since 2016. The company focuses on the discovery, development, and commercialization of biologic technologies, particularly in the field of bone regeneration and tissue repair. With operations extending to the Netherlands and the USA, Kuros Biosciences leverages its global presence to advance its innovative solutions in the healthcare sector. The company's product portfolio includes advanced biomaterials and biologics designed to enhance the body's natural healing processes, catering to the needs of patients and healthcare providers worldwide.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

21.0%1Y
1,674%3Y
947%5Y

Performance

52.3%1Y
71.0%3Y
63.8%5Y

Volatility

Market cap

1123 M

Market cap (USD)

Daily traded volume (Shares)

199,207

Daily traded volume (Shares)

1 day high/low

22.25 / 20.6

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

1 votes
Performance:
starstarstarstarstar
3.00
Innovation:
starstarstarstarstar
5.00
Society:
starstarstarstarstar
4.00
Nature:
starstarstarstarstar
4.00
Roger Schaad
Switzerland, 04 Mar 2025
star star star star star
Grosses Potenzial vorhanden

EQUITIES OF THE SAME SECTOR

Endava PLC
Endava PLC Endava PLC Valor: 42666274
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.93%USD 4.44
Fabrinet
Fabrinet Fabrinet Valor: 3595304
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
9.96%USD 600.91
Trinet Group Inc
Trinet Group Inc Trinet Group Inc Valor: 1075234
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.47%USD 37.94
StoneCo Ltd
StoneCo Ltd StoneCo Ltd Valor: 44023913
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.57%USD 13.98
Bonesupport Holding AB
Bonesupport Holding AB Bonesupport Holding AB Valor: 36497524
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.22%SEK 178.90
Meier Tobler Group Ltd.
Meier Tobler Group Ltd. Meier Tobler Group Ltd. Valor: 20806262
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.72%CHF 35.20
Oxford Metrics PLC
Oxford Metrics PLC Oxford Metrics PLC Valor: 1222541
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.46%GBP 0.44
Acadia Pharmaceuticals Inc
Acadia Pharmaceuticals Inc Acadia Pharmaceuticals Inc Valor: 1184425
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.14%USD 20.96
Acer Incorporated
Acer Incorporated Acer Incorporated Valor: 1393451
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.86%EUR 4.14
United Therapeutics Corp
United Therapeutics Corp United Therapeutics Corp Valor: 848383
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.03%USD 531.82